SAGAlim-MT-500
Description_Effects
SAGAlim-MT-500 is a combination medicine used to control blood sugar levels in individuals with type 2 diabetes mellitus. It contains Glimepiride and Metformin, two widely used oral antidiabetic agents that work through different mechanisms to manage diabetes more effectively. Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin, thereby helping to lower blood sugar levels, especially after meals. Metformin, on the other hand, is a biguanide that works by reducing the production of glucose in the liver, decreasing its absorption in the intestines, and improving the body's sensitivity to insulin. This dual-action formulation provides better glycemic control than either medicine alone, making it suitable for patients whose blood sugar is not adequately managed by diet, exercise, or single-drug therapy. SAGAlim-MT-500 helps prevent long-term complications of diabetes such as nerve damage, kidney issues, heart disease, and eye problems. It should be taken with meals to minimize gastrointestinal side effects like nausea or stomach upset. Regular monitoring of blood sugar, adherence to dietary guidelines, and routine physical activity are essential for the best results. This medicine should be used under medical supervision, especially in patients with kidney, liver, or heart conditions, and dosage should not be adjusted without a doctor's advice.
